Simplified Approaches to Medium-Sized Heterocycles for the Synthesis of Bioactive Small Molecules
Project Number5R01GM123098-04
Contact PI/Project LeaderWENGRYNIUK, SARAH ELIZABETH
Awardee OrganizationTEMPLE UNIV OF THE COMMONWEALTH
Description
Abstract Text
PROJECT SUMMARY
The goal of this proposal is to develop simplified approaches to the construction of diverse medium-
sized oxygen and nitrogen heterocycles that can be applied to the synthesis and complexity-building
diversification of bioactive small molecules. Medium-ring heterocycles are ubiquitous in naturally occurring
bioactive molecules, however these scaffolds remain largely absent from pharmaceutical drug scaffolds due to
challenges associated with their synthesis. In order to address rising concerns regarding the lack of chemical
space explored by current therapeutic molecules, we propose methods that enable the use of readily available
alcohols and amines as functional handles for the facile synthesis of medium-sized heterocycles. Preliminary
work in our laboratory has discovered a novel electrophilic heteroatom rearrangement of benzylic alcohols
facilitated by a unique class of (poly)cationic hypervalent iodine reagents that allows direct access to diverse
medium-ring ethers. The first aim of this proposal is the continued development of this novel transformation to
include secondary and tertiary alcohols as well as amine substrates, providing a general platform for medium-
ring heterocycle synthesis. The second aim is the further development of our enabling (poly)cationic λ3-
iodanes, both through detailed reactivity studies as well as novel derivative syntheses, in order to facilitate their
adoption as broadly utilized synthetic reagents. We will also employ these reagents as a novel manifold for the
synthesis of chiral hypervalent iodine scaffolds. The third aim of this proposal will utilize our methodology as an
enabling platform for complex medium-sized ether analogues of the promising chemotherapeutic lead
podophyllotoxin, a compound that has seen little clinical development to date due to limited tolerance for
traditional medicinal chemistry diversification. The work is significant because the development of simplified
approaches to medium-ring heterocycles will expand the chemical space available for drug discovery by
providing previously inaccessible analogues and facilitating more rapid syntheses of complex bioactive natural
products. Furthermore, the development of promising (poly)cationic λ3-iodanes will provide the synthetic
community with a powerful new toolkit of synthetic reagents.
Public Health Relevance Statement
Project Narrative
The proposed research is relevant to public health as it develops simplified approaches to challenging
medium-ring heterocycles, expanding the available chemical space for drug discovery. Medium-ring
heterocycles are ubiquitous in naturally occurring bioactive molecules, however these scaffolds remain largely
absent from pharmaceutical small molecule drug libraries due to challenges associated with their synthesis.
The goal of this proposal is to develop an enabling platform for the expedient synthesis of medium-ring
scaffolds in complex natural products as well as for the diversification of medicinal chemistry libraries.
No Sub Projects information available for 5R01GM123098-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01GM123098-04
Patents
No Patents information available for 5R01GM123098-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01GM123098-04
Clinical Studies
No Clinical Studies information available for 5R01GM123098-04
News and More
Related News Releases
No news release information available for 5R01GM123098-04
History
No Historical information available for 5R01GM123098-04
Similar Projects
No Similar Projects information available for 5R01GM123098-04